183 related articles for article (PubMed ID: 33982656)
1. A Link Between Chemical Structure and Biological Activity in Triterpenoids.
Zang L; Xu H; Huang C; Wang C; Wang R; Chen Y; Wang L; Wang H
Recent Pat Anticancer Drug Discov; 2022; 17(2):145-161. PubMed ID: 33982656
[TBL] [Abstract][Full Text] [Related]
2. Natural Product Triterpenoids and Their Semi-Synthetic Derivatives with Potential Anticancer Activity.
Ren Y; Kinghorn AD
Planta Med; 2019 Aug; 85(11-12):802-814. PubMed ID: 30658371
[TBL] [Abstract][Full Text] [Related]
3. Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: potential role in prevention and therapy of cancer.
Shanmugam MK; Nguyen AH; Kumar AP; Tan BK; Sethi G
Cancer Lett; 2012 Jul; 320(2):158-70. PubMed ID: 22406826
[TBL] [Abstract][Full Text] [Related]
4. Identification of the anti-breast cancer targets of triterpenoids in Liquidambaris Fructus and the hints for its traditional applications.
Qian P; Mu XT; Su B; Gao L; Zhang DF
BMC Complement Med Ther; 2020 Nov; 20(1):369. PubMed ID: 33246450
[TBL] [Abstract][Full Text] [Related]
5. Pentacyclic triterpenoids with nitrogen- and sulfur-containing heterocycles: synthesis and medicinal significance.
Kvasnica M; Urban M; Dickinson NJ; Sarek J
Nat Prod Rep; 2015 Sep; 32(9):1303-30. PubMed ID: 26030604
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Tumour-Related Signaling Pathways by Natural Pentacyclic Triterpenoids and their Semisynthetic Derivatives.
Markov AV; Zenkova MA; Logashenko EB
Curr Med Chem; 2017; 24(13):1277-1320. PubMed ID: 28078994
[TBL] [Abstract][Full Text] [Related]
7. Techniques for the analysis of pentacyclic triterpenoids in medicinal plants.
Xu C; Wang B; Pu Y; Tao J; Zhang T
J Sep Sci; 2018 Jan; 41(1):6-19. PubMed ID: 28862795
[TBL] [Abstract][Full Text] [Related]
8. Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
Salvador JAR; Leal AS; Valdeira AS; Gonçalves BMF; Alho DPS; Figueiredo SAC; Silvestre SM; Mendes VIS
Eur J Med Chem; 2017 Dec; 142():95-130. PubMed ID: 28754470
[TBL] [Abstract][Full Text] [Related]
9. Celastrol as a pentacyclic triterpenoid with chemopreventive properties.
Yadav P; Jaswal V; Sharma A; Kashyap D; Tuli HS; Garg VK; Das SK; Srinivas R
Pharm Pat Anal; 2018 Jul; 7(4):155-167. PubMed ID: 29882724
[TBL] [Abstract][Full Text] [Related]
10. Pentacyclic Triterpenoids with Nitrogen-Containing Heterocyclic Moiety, Privileged Hybrids in Anticancer Drug Discovery.
Khwaza V; Mlala S; Oyedeji OO; Aderibigbe BA
Molecules; 2021 Apr; 26(9):. PubMed ID: 33918996
[TBL] [Abstract][Full Text] [Related]
11. Bioactive Pentacyclic Triterpenes Trigger Multiple Signalling Pathways for Selective Apoptosis Leading to Anticancer Efficacy: Recent Updates and Future Perspectives.
Banerjee J; Samanta S; Ahmed R; Dash SK
Curr Protein Pept Sci; 2023; 24(10):820-842. PubMed ID: 37073661
[TBL] [Abstract][Full Text] [Related]
12. Dammarane triterpenoids for pharmaceutical use: a patent review (2005 - 2014).
Cao J; Zhang X; Qu F; Guo Z; Zhao Y
Expert Opin Ther Pat; 2015 Jul; 25(7):805-17. PubMed ID: 25892194
[TBL] [Abstract][Full Text] [Related]
13. Selected plant triterpenoids and their amide derivatives in cancer treatment: A review.
Özdemir Z; Wimmer Z
Phytochemistry; 2022 Nov; 203():113340. PubMed ID: 35987401
[TBL] [Abstract][Full Text] [Related]
14. Natural barrigenol-like triterpenoids: A comprehensive review of their contributions to medicinal chemistry.
Zhang X; Zhang S; Yang Y; Wang D; Gao H
Phytochemistry; 2019 May; 161():41-74. PubMed ID: 30818173
[TBL] [Abstract][Full Text] [Related]
15. Known Triterpenes and their Derivatives as Scaffolds for the Development of New Therapeutic Agents for Cancer.
Peron G; Marzaro G; Dall Acqua S
Curr Med Chem; 2018; 25(10):1259-1269. PubMed ID: 28820068
[TBL] [Abstract][Full Text] [Related]
16. Ursolic acid derivatives for pharmaceutical use: a patent review (2012-2016).
Hussain H; Green IR; Ali I; Khan IA; Ali Z; Al-Sadi AM; Ahmed I
Expert Opin Ther Pat; 2017 Sep; 27(9):1061-1072. PubMed ID: 28637397
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of boswellic acids: a patent review (1990-2015).
Hussain H; Al-Harrasi A; Csuk R; Shamraiz U; Green IR; Ahmed I; Khan IA; Ali Z
Expert Opin Ther Pat; 2017 Jan; 27(1):81-90. PubMed ID: 27646163
[TBL] [Abstract][Full Text] [Related]
18. Natural products of pentacyclic triterpenoids: from discovery to heterologous biosynthesis.
Li Y; Wang J; Li L; Song W; Li M; Hua X; Wang Y; Yuan J; Xue Z
Nat Prod Rep; 2023 Aug; 40(8):1303-1353. PubMed ID: 36454108
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic Potential of a-Azepano- and 3-Amino-3,4-SeCo-Triterpenoids.
Kazakova O; Smirnova I; Tret'yakova E; Csuk R; Hoenke S; Fischer L
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567783
[TBL] [Abstract][Full Text] [Related]
20. Insilico Screening of Pentacyclic Triterpenoids against Vascular Dementia Target's.
Roja R; Kalakotla S; Ravula AR; Boyina HK; Navanita SK; Vallika PBS; Gangarapu K; Devarakonda KP; Bakshi V
Adv Exp Med Biol; 2023; 1423():237-243. PubMed ID: 37525050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
